Ignite Creation Date:
2024-07-17 @ 11:00 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06495125
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-07-02
Brief Title:
Defactinib Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer
Sponsor:
Emory University
Organization:
Emory University
Organization Data
Organization:
Emory University
Class:
OTHER
Study ID:
STUDY00006144
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Emory University
Lead Sponsor Class:
OTHER
Responsible Party:
Conor Steuer
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Emory University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |